Over $42 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Over $42 Million Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Although US stocks closed mostly lower on Monday, there were a few notable insider trades.
尽管周一美国股市收盘大多走低，但仍有一些值得注意的内幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
当内部人士购买股票时，这表明他们对公司前景充满信心，或者他们认为股票很划算。无论哪种方式，这都预示着做多该股的机会。不应将内幕购买视为做出投资或交易决策的唯一指标。充其量，它可以为购买决定提供信心。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近一些值得注意的内幕收购。欲了解更多，请查看 本辛加的内幕交易 平台。
Acrivon Therapeutics
Acrivon Therapeu
- The Trade: Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Director Rajeev Shah acquired a total of 4,810,508 shares an average price of $12.50. To acquire these shares, it cost around $42.37 million.
- What's Happening: The company recently priced its initial public offering of 7,550,000 shares at $12.50 per share.
- What Acrivon Therapeutics Does: Acrivon Therapeutics is clinical stage biopharmaceutical company.
- 交易： Acrivon Therapeutics, Inc （纳斯达克股票代码：ACRV）导演拉杰夫·沙阿 共收购了 4,810,508 股股票 平均价格为12.50美元。收购这些股票的成本约为4237万美元。
- 发生了什么： 该公司最近将其首次公开募股7,55万股定价为每股12.50美元。
- Acrivon Therapeutics 的作用： Acrivon Therapeutics是一家临床阶段的生物制药公司。
Ryan Specialty
瑞安专业
- The Trade: Ryan Specialty Holdings, Inc. (NYSE:RYAN) CEO Patrick Ryan acquired a total of 288,038 shares at an average price of $38.26. To acquire these shares, it cost around $11.02 million.
- What's Happening: The company recently posted Q3 results.
- What Ryan Specialty Does: Ryan Specialty Holdings Inc, formerly Ryan Specialty Group Holdings Inc is a service provider of specialty products and solutions for insurance brokers, agents and carriers.
- 交易： 瑞安专业控股有限公司 （纽约证券交易所代码：RYAN）首席执行官帕特里克· 共收购了288,038股股票 平均价格为38.26美元。收购这些股票的成本约为1102万美元。
- 发生了什么： 该公司最近公布了第三季度业绩。
- Ryan Specialty 的作用 Ryan Specialty Holdings Inc，前身为Ryan Specialty Group Holdings Inc，是一家为保险经纪人、代理商和承运人提供
Don't forget to check out our premarket coverage here .
别忘了在这里查看我们的上市前报道。
Also check this: Amazon To $119? Here Are 5 Other Price Target Changes For Tuesday
另请看这个：亚马逊到了 119 美元？以下是周二的其他 5 项目标价格变化
Greenhill & Co
Greenhill & Co
- The Trade: Greenhill & Co., Inc. (NYSE:GHL) Chairman and CEO Scott L Bok bought a total of 47,850 shares at an average price of $10.09. To acquire these shares, it cost around $482.99 thousand.
- What's Happening: Greenhill recently reported better-than-expected Q3 sales results.
- What Greenhill & Co Does: Greenhill & Co Inc is an independent investment bank that provides financial and strategic advice on significant domestic and cross-border mergers and acquisitions, divestitures, restructurings, financings, capital raising and other transactions to a diverse client base, including corporations, partnerships, institutions and governments globally.
- 交易： Greenhill & Co., Inc. （纽约证券交易所代码：GHL）董事长兼首席执行官斯科特·博克 共购买了 47,850 股股票 平均价格为10.09美元。收购这些股票的成本约为482.99万美元。
- 发生了什么： 格林希尔最近公布的第三季度销售业绩好于预期。
- Greenhill & Co 在做什么： Greenhill & Co Inc是一家独立的投资银行，就重大的国内和跨境并购、剥离、重组、融资、融资和其他交易向包括全球公司、合伙企业、机构和政府在内的多元化客户群提供财务和战略建议。
译文内容由第三方软件翻译。